Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerg Microbes Infect
Hauptverfasser: Zhang, Ya-Nan, Zhang, Qiu-Yan, Li, Xiao-Dan, Xiong, Jin, Xiao, Shu-Qi, Wang, Zhen, Zhang, Zhe-Rui, Deng, Cheng-Lin, Yang, Xing-Lou, Wei, Hong-Ping, Yuan, Zhi-Ming, Ye, Han-Qing, Zhang, Bo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2020
Schlagworte:
Letter
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448857/
https://ncbi.nlm.nih.gov/pubmed/32432977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1772676
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge